fluocinolone acetonide has been researched along with Intraocular Pressure in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.05) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (16.22) | 29.6817 |
| 2010's | 40 (54.05) | 24.3611 |
| 2020's | 19 (25.68) | 2.80 |
| Authors | Studies |
|---|---|
| Delyfer, MN; Jomaa, E; Schweitzer, C | 1 |
| Buhl, L; Kern, C; Thurau, S | 1 |
| Abdin, AD; Löw, U; Munteanu, C; Seitz, B; Wykrota, AA | 1 |
| Feinstein, E; Palestine, AG; Pecen, PE; Sadowsky, AJ | 1 |
| Busch, C; Jochmann, C; Rehak, M; Unterlauft, JD; Wiedemann, P | 1 |
| Castro-de-Sousa, JP; Kaku, P; Marques-Neves, C; Martins, D; Nascimento, J; Prates Canelas, J; Reis, P; Sampaio, A; Urbano, H; Vaz-Pereira, S | 1 |
| Cai, CX; Grewal, DS; Jaffe, GJ; Keenan, RT; Skalak, C | 1 |
| Baynes, K; Cao, JL; Eisengart, J; Lowder, CY; Sharma, S; Srivastava, SK | 1 |
| Eichenbaum, D; Holekamp, NM; Kaba, S; Kiernan, DF; Mansour, SE; Roth, DB; Werts, E | 1 |
| Cutino, A; Eaton, AM; Riemann, CD | 1 |
| Jaffe, GJ; Pavesio, CE | 1 |
| Altaweel, MM; Ansari, H; Dunn, JP; Elner, SG; Friedman, DS; Holbrook, JT; Jabs, DA; Kempen, JH; Lim, LL; Sugar, EA; Van Natta, ML | 1 |
| Gupta, R; Sharma, S | 1 |
| Agodi, A; Avitabile, T; Barchitta, M; Bonfiglio, V; Caselgrandi, P; Cennamo, G; Fallico, M; Furino, C; Longo, A; Lotery, A; Marolo, P; Maugeri, A; Reibaldi, M; Russo, A; Ventre, L | 1 |
| Cao, JL; Eisengart, J | 1 |
| Heinz, C; Pavesio, C | 1 |
| Krambeer, C; Paggiarino, D; Singer, MA | 1 |
| Han, Y; Hennein, L; Lowry, EA | 1 |
| Lam, DSC; Wan, KH | 1 |
| Bailey, C; Chakravarthy, U; Lotery, A; Menon, G; Talks, J | 1 |
| Berni, E; Currie, CJ; Holden, SE; Owens, DR | 1 |
| Currie, CJ; Holden, SE; Owens, DR | 1 |
| Cho, H; Davoudi, S; Guo, R; Lobo, AM; Papaliodis, GN; Sevgi, DD; Shen, LQ; Sobrin, L; Talcott, KE; Turalba, A | 1 |
| Beirão, M; Coelho, J; Correia, N; Ferreira, N; Meireles, A; Pessoa, B | 1 |
| Habib, MS | 1 |
| Chen, X; Fekrat, S; Finn, AP; Ong, SS; Thomas, AS; Walter, SD | 1 |
| Bailey, C; Castro de Sousa, JP; Chakravarthy, U; Koch, FHJ; Taylor, SR | 1 |
| Gericke, A; Pfeiffer, N; Wasielica-Poslednik, J | 1 |
| Augustin, AJ; Bopp, S; Duncker, T; Fechner, M; Gentsch, D; Höh, H; Holz, F; Khoramnia, R; Ksinsik, C; Neuhann, T; Sandner, D; Seitz, B; Sekundo, W; Spitzer, M; Warscher, M; Winkgen, AM | 1 |
| Lowder, CY; Punjabi, OS; Sears, JE; Shen, BY; Singh, RP | 1 |
| Burkholder, BM; Dunn, JP; Nguyen, QD; Thorne, JE; Wang, J | 1 |
| Alexander, J; Ansari, H; Burke, A; Friedman, DS; Holbrook, JT; Katz, J; Kempen, JH; Lightman, SL; Reed, SB; Thorne, JE | 1 |
| Beardsley, RM; Flaxel, CJ; Messenger, WB | 1 |
| Aziz, K; Bajwa, A; Foster, CS | 1 |
| Albini, T; Bena, J; Goldstein, DA; Nguyen, QD; Parekh, A; Srivastava, S | 1 |
| Bailey, C; Loewenstein, A; Massin, P; Yang, Y | 1 |
| Foster, CS; He, Y; Maleki, A; Preble, JM; Silpa-Archa, S; Swan, RT | 1 |
| Campochiaro, PA; Green, K; Parrish, RK; Pearson, PA; Traverso, CE | 1 |
| Chang, IT; Chen, PP; Gupta, D; Slabaugh, MA; Vemulakonda, GA | 1 |
| Cho, BJ; Do, DV; Goldstein, DA; Heo, JW; Nguyen, QD; Sepah, YJ | 1 |
| Ashton, P; Jaffe, GJ; Keenan, RT; Lin, P; Skalak, C; Stinnett, SS | 1 |
| Enanoria, WT; Han, Y; Hennein, L; Hou, J; Jiang, Z; Lowry, EA; Stewart, JM | 1 |
| Foster, CS; Lasave, AF; Ma, L; Maleki, A; Swan, RT | 1 |
| Burkholder, BM; Khan, IR; Reddy, AK; Thorne, JE | 1 |
| Alfaqawi, F; Chavan, R; Elsherbiny, S; Lip, PL; Mitra, A; Mushtaq, B | 1 |
| Fekrat, S; Jaffe, GJ; Ramchandran, RS; Stinnett, SS | 1 |
| Carlson, AN; Chieh, JJ; Jaffe, GJ | 1 |
| Callanan, DG; Comstock, TL; Jaffe, GJ; Martin, DF; Pearson, PA | 1 |
| Ratiglia, R; Staurenghi, G; Viola, F | 1 |
| Fischer, DH; Folk, JC; Gehrs, KM; Goldstein, DA; Lopez, JS; Mahajan, VB | 1 |
| Abrams, GW; Ashton, P; Glybina, IV; Iezzi, R; Kennedy, A | 1 |
| Fujii, S; Kuno, N | 1 |
| Herndon, LW; Jaffe, GJ; Malone, PE; Muir, KW | 1 |
| Billman, K; Bloom, S; Brown, DM; Busquets, M; Campochiaro, PA; Ciulla, T; Feiner, L; Green, K; Hafiz, G; Kane, F; Kapik, B; Sabates, N; Shah, SM | 1 |
| Ansari, H; Kempen, JH | 1 |
| Flynn, HW; Schwartz, SG | 1 |
| Kadam, R; Kompella, UB; Thakur, A | 1 |
| Altaweel, MM; Davis, JL; Feuer, WJ; Galor, A; Madow, B | 1 |
| Bollinger, K; Kaiser, PK; Kim, J; Lowder, CY; Smith, SD | 1 |
| Chow, J; Dayani, PN; Jaffe, GJ; Stinnett, SS | 1 |
| Ashton, P; Callanan, D; Comstock, TL; Eliott, D; Ip, M; Levy, B; Mann, ES; Morse, LS; Pearson, PA | 1 |
| Jaffe, GJ; Jain, N; Stinnett, SS | 1 |
| Braverman, R; Mandava, N; Oliver, SC; Olson, JL; Patel, CC; Quiroz-Mercado, H | 1 |
| Abrams, GW; Ahmad, ZM; Hughes, BA; Mahmoud, TH | 1 |
| Holekamp, NM; Pearson, A; Thomas, MA | 1 |
| Ashton, P; Branchaud, B; Butuner, Z; Jaffe, GJ; McCallum, RM; Skalak, C | 1 |
| Callanan, D; Comstock, T; Jaffe, GJ; Levy, B; Martin, D; Pearson, PA | 1 |
| Callanan, DG; Comstock, TL; Godfrey, DG; Goldstein, DA; Hall, A; Jaffe, GJ; Pearson, PA; Usner, DW | 1 |
| Jaffe, GJ | 1 |
| Ashton, P; Ben-Nun, J; Dunn, JP; Guo, H; Jaffe, GJ | 1 |
| Bennett, A; Eakins, KE; Whitelocke, RA | 1 |
| Keipert, JA | 1 |
| Contaxis, I; Smith, JC; Sweet, D; Van Dolah, J; Wood, DC | 1 |
8 review(s) available for fluocinolone acetonide and Intraocular Pressure
| Article | Year |
|---|---|
Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema | 2021 |
ILUVIEN
Topics: Angiogenesis Inhibitors; Cataract; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Models, Economic; Quality of Life; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.
Topics: Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intraocular Pressure; Light Coagulation; Macular Edema; Quality of Life; Triamcinolone; Vascular Endothelial Growth Factor A; Vitrectomy | 2013 |
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.
Topics: Cataract; Dexamethasone; Diabetic Retinopathy; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2015 |
Biodegradable intraocular therapies for retinal disorders: progress to date.
Topics: Absorbable Implants; Angiogenesis Inhibitors; Clinical Trials as Topic; Dexamethasone; Diabetic Retinopathy; Drug Administration Routes; Drug Delivery Systems; Epithelial Cells; Fluocinolone Acetonide; Humans; Intraocular Pressure; Macular Degeneration; Macular Edema; Retinal Diseases; Retinal Vein Occlusion; Uveitis; Vitreous Body | 2010 |
Fluocinolone acetonide implantable device for diabetic retinopathy.
Topics: Cataract; Diabetic Retinopathy; Drug Administration Routes; Drug Delivery Systems; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Acute anterior uveitis and prostaglandins.
Topics: Acetaminophen; Administration, Topical; Animals; Anti-Inflammatory Agents; Aqueous Humor; Eye; Fluocinolone Acetonide; Fluorescein Angiography; Humans; Hydrocortisone; Indomethacin; Intraocular Pressure; Phloretin; Prostaglandins; Rabbits; Salicylates; Uveitis; Uveitis, Anterior | 1973 |
The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adrenal Glands; Age Factors; Anti-Inflammatory Agents; Betamethasone; Child; Fludrocortisone; Fluocinolone Acetonide; Growth; Humans; Hydrocortisone; Infant; Intraocular Pressure; Pituitary-Adrenal System; Skin Absorption; Triamcinolone | 1971 |
18 trial(s) available for fluocinolone acetonide and Intraocular Pressure
| Article | Year |
|---|---|
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Topics: Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prospective Studies; Recurrence; Time Factors; Tomography, Optical Coherence; Uveitis, Posterior; Visual Acuity | 2020 |
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy.
Topics: Adult; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prospective Studies; Risk Factors; Treatment Outcome; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2020 |
IOP Elevation in Patients Treated With Fluocinolone Acetonide Insert for Chronic Noninfectious Uveitis Affecting the Posterior Segment.
Topics: Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Prospective Studies; Uveitis; Uveitis, Posterior; Visual Acuity | 2021 |
Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.
Topics: Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Male; Middle Aged; Optic Nerve Diseases; Risk Factors; Surveys and Questionnaires; Tonometry, Ocular; Uveitis; Visual Acuity; Visual Fields | 2013 |
Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Tenon Capsule; Tonometry, Ocular; Uveitis; Visual Acuity | 2015 |
Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatmen
Topics: Adult; Aged; Anti-Inflammatory Agents; Cataract; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prednisone; Prospective Studies; Quality of Life; Risk Factors; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity | 2015 |
Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME Trials.
Topics: Antihypertensive Agents; Diabetic Retinopathy; Disease Management; Dose-Response Relationship, Drug; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Practice Guidelines as Topic; Time Factors; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Visual Acuity; Vitreous Body | 2016 |
FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2016 |
Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Topics: Adult; Anti-Inflammatory Agents; Delayed-Action Preparations; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prospective Studies; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Young Adult | 2016 |
Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Delayed-Action Preparations; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity | 2008 |
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Postoperative Complications; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2008 |
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Topics: Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Drug Delivery Systems; Drug Implants; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Prospective Studies; Retina; Tandem Mass Spectrometry; Tomography, Optical Coherence; Visual Acuity; Vitreous Body | 2010 |
Validation of a photographic vitreous haze grading technique for clinical trials in uveitis.
Topics: Cost-Benefit Analysis; Diagnostic Techniques, Ophthalmological; Drug Implants; Eye Diseases; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Observer Variation; Photography; Reproducibility of Results; Retrospective Studies; Uveitis; Visual Acuity; Vitreous Body | 2011 |
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
Topics: Cataract; Diabetic Retinopathy; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retina; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitreous Body | 2011 |
The safety profile of long-term, high-dose intraocular corticosteroid delivery.
Topics: Adult; Angioid Streaks; Cataract; Choroid Diseases; Choroidal Neovascularization; Drug Delivery Systems; Drug Implants; Feasibility Studies; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Histoplasmosis; Humans; Intraocular Pressure; Male; Middle Aged; Myopia, Degenerative; Ocular Hypertension; Prospective Studies; Retinal Vein Occlusion; Safety; Treatment Outcome; Visual Acuity | 2005 |
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2005 |
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Child; Double-Blind Method; Drug Implants; Female; Filtering Surgery; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2006 |
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Drug Delivery Systems; Drug Evaluation; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Pilot Projects; Prospective Studies; Uveitis; Visual Acuity; Visual Fields | 2000 |
48 other study(ies) available for fluocinolone acetonide and Intraocular Pressure
| Article | Year |
|---|---|
Elevated Intraocular Pressure Associated With Anterior Chamber Migration of Fluocinolone Acetonide Implant 1 Year After Administration.
Topics: Anterior Chamber; Drug Implants; Fluocinolone Acetonide; Glaucoma; Humans; Intraocular Pressure | 2022 |
Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study.
Topics: Cataract; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Uveitis; Uveitis, Posterior | 2023 |
Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Topics: Dexamethasone; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide | 2023 |
Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation.
Topics: Adolescent; Adult; Aged; Child; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Postoperative Complications; Retrospective Studies; Risk Factors; Uveitis, Posterior | 2020 |
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Topics: Aged; Bevacizumab; Dexamethasone; Diabetic Retinopathy; Drug Administration Schedule; Drug Implants; Drug Substitution; Female; Fluocinolone Acetonide; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
Topics: Aged; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Quality of Life; Retrospective Studies; Time Factors; Treatment Outcome; Visual Acuity | 2020 |
Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
Topics: Adult; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Panuveitis; Recurrence; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity | 2020 |
Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
Topics: Adult; Aged; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Prosthesis Implantation; Retrospective Studies; Tonometry, Ocular; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2020 |
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.
Topics: Aged; Diabetic Retinopathy; Dose-Response Relationship, Drug; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Prospective Studies; Time Factors; Treatment Outcome; Visual Acuity | 2021 |
Reduction in Retinal Thickness Fluctuations After Treatment With Fluocinolone Acetonide Implant for DME: A Post-Hoc Analysis of the USER Study.
Topics: Aged; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Retina; Retrospective Studies; Visual Acuity | 2020 |
Letter to the Editor: Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
Topics: Fluocinolone Acetonide; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Uveitis | 2021 |
Response to Letter to the Editor: Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
Topics: Fluocinolone Acetonide; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Uveitis | 2021 |
Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
Topics: Cataract; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Recurrence; Treatment Outcome; Uveitis; Visual Acuity | 2022 |
Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert).
Topics: Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Treatment Outcome; Uveitis | 2017 |
Efficacy of Combined Retisert and Ahmed Glaucoma Valve for Medically Uncontrolled Uveitis and Glaucoma.
Topics: Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Treatment Outcome; Uveitis | 2017 |
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.
Topics: Aged; Diabetic Retinopathy; Dose-Response Relationship, Drug; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Retrospective Studies; Time Factors; Treatment Outcome; United Kingdom; Visual Acuity | 2017 |
Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes.
Topics: Aged; Cohort Studies; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 µg intravitreal implant in people with diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Coated Materials, Biocompatible; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Male; Middle Aged; Prosthesis Design; Retrospective Studies; Treatment Outcome; Uveitis, Anterior; Visual Acuity; Young Adult | 2017 |
Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Topics: Aged; Chronic Disease; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Visual Acuity; Vitrectomy | 2018 |
BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
Topics: Aged; Basement Membrane; Drug Implants; Endotamponade; Epiretinal Membrane; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Visual Acuity; Vitrectomy | 2021 |
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries.
Topics: Aged; Diabetic Retinopathy; Drug Implants; Europe; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity | 2019 |
Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report.
Topics: Amnion; Anti-Inflammatory Agents; Cornea; Corneal Diseases; Drug Implants; Female; Fluocinolone Acetonide; Humans; Intraocular Pressure; Intravitreal Injections; Middle Aged; Sjogren's Syndrome; Treatment Outcome; Visual Acuity; Vitrectomy | 2019 |
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN
Topics: Aged; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Germany; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tonometry, Ocular; Visual Acuity | 2020 |
Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
Topics: Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity | 2013 |
Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis.
Topics: Adult; Aged; Aged, 80 and over; Birdshot Chorioretinopathy; Chorioretinitis; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Postoperative Complications; Postoperative Period; Retrospective Studies; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2013 |
Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Birdshot Chorioretinopathy; Cataract; Chorioretinitis; Delayed-Action Preparations; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2014 |
Short-Wavelength Automated Perimetry Parameters at Baseline and Following Remission in Patients With Birdshot Retinochoroidopathy.
Topics: Adult; Aged; Birdshot Chorioretinopathy; Chorioretinitis; Coloring Agents; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intraocular Pressure; Male; Middle Aged; Retrospective Studies; Vision Disorders; Visual Acuity; Visual Field Tests; Visual Fields | 2016 |
Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
Topics: Adult; Cataract; Cataract Extraction; Chronic Disease; Drug Implants; Female; Filtering Surgery; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Tonometry, Ocular; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2016 |
Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert).
Topics: Adult; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 2016 |
Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma.
Topics: Drug Implants; Female; Fluocinolone Acetonide; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Retrospective Studies; Trabeculectomy; Uveitis; Vitreous Body | 2016 |
Iluvien Implantation for Uveitis and Uveitic Macular Edema.
Topics: Adult; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Tomography, Optical Coherence; Uveitis; Visual Acuity; Vitreous Body | 2018 |
Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; United Kingdom; Visual Acuity | 2017 |
Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Topics: Chronic Disease; Drug Delivery Systems; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitreous Body | 2008 |
Uveitis treated with fluocinolone acetonide implants.
Topics: Antihypertensive Agents; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Ocular Hypertension; Trabeculectomy; Uveitis | 2009 |
Management of sympathetic ophthalmia with the fluocinolone acetonide implant.
Topics: Adult; Aged; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Middle Aged; Ophthalmia, Sympathetic; Retrospective Studies; Treatment Outcome; Visual Acuity | 2009 |
Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide.
Topics: Animals; Cell Count; Drug Delivery Systems; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Glucocorticoids; Intraocular Pressure; Male; Microglia; Neuroprotective Agents; Photoreceptor Cells, Vertebrate; Rats; Rats, Mutant Strains; Retinitis Pigmentosa; Vitreous Body | 2009 |
Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Drug Implants; Feasibility Studies; Female; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2010 |
Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma.
Topics: Combined Modality Therapy; Drug Implants; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Uveitis | 2010 |
Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.
Topics: Animals; Budesonide; Cataract; Cattle; Chromatography, High Pressure Liquid; Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Lens, Crystalline; Middle Aged; Prednisolone; Tandem Mass Spectrometry; Trabecular Meshwork; Triamcinolone Acetonide | 2011 |
Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Drug Implants; Female; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Retrospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2011 |
Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Middle Aged; Ocular Hypotension; Recurrence; Retrospective Studies; Silicone Oils; Tonometry, Ocular; Uveitis; Visual Acuity; Vitrectomy; Vitreous Body | 2011 |
Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
Topics: Aged; Cataract Extraction; Chronic Disease; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Trabeculectomy; Visual Acuity; Vitreous Body | 2012 |
Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
Topics: Adolescent; Anti-Inflammatory Agents; Child; Drug Implants; Female; Fluocinolone Acetonide; Humans; Intraocular Pressure; Male; Pilot Projects; Postoperative Complications; Retrospective Studies; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2012 |
Combined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitis.
Topics: Adult; Anesthesia, Local; Antihypertensive Agents; Cataract; Cataract Extraction; Chronic Disease; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Posterior Eye Segment; Postoperative Complications; Retrospective Studies; Sclerostomy; Suture Techniques; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitrectomy; Vitreous Body | 2012 |
Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Child; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Randomized Controlled Trials as Topic; Time Factors; Trabeculectomy; Treatment Outcome; Uveitis | 2007 |
Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
Topics: Adult; Chronic Disease; Drug Delivery Systems; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Retreatment; Secondary Prevention; Uveitis, Posterior; Visual Acuity | 2008 |
A study of DMSO and steroids in rabbit eyes.
Topics: Animals; Aqueous Humor; Blood Chemical Analysis; Body Weight; Crystallins; Dimethyl Sulfoxide; Drug Synergism; Eye; Fluocinolone Acetonide; Intraocular Pressure; Organ Size; Proteins; Rabbits; Urine | 1967 |